Cargando…
Remimazolam as a Primary Agent for Brief Invasive and Noninvasive Procedures: A Case Series
Remimazolam is a novel benzodiazepine with sedative and amnestic properties similar to midazolam. Ester metabolism results in a half-life of 5 - 10 min and a limited context sensitive half-life. We present preliminary retrospective experience with its use as a primary agent for procedural sedation f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079368/ https://www.ncbi.nlm.nih.gov/pubmed/37035849 http://dx.doi.org/10.14740/jocmr4870 |